Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted solutions in three infusion bags

Author:

D’Huart Elise12,Sacrez Matthieu1,Vigneron Jean12,Sobalak Nathalie1,Demoré Béatrice123

Affiliation:

1. Pharmacy Department , University Hospital , Vandœuvre-lès-Nancy , France

2. Infostab, Non-Profit Association , Heillecourt , France

3. Université de Lorraine , Nancy , France

Abstract

Abstract Objectives To the best of our knowledge, few studies have been published on the stability of cabazitaxel in infusion bags. Stabilis® database has selected a study demonstrating the stability of this molecule at 0.15 mg/mL for 28 days at 4 °C and 25 °C in polyolefin bags. The aim of this work was to study the physicochemical stability of Cabazitaxel Zentiva® solutions in vials after “opening” with a vented ChemoClave® Spike, at 25 °C, protected from light and in solutions diluted at 0.1 and 0.26 mg/mL in 0.9 % sodium chloride (0.9 % NaCl) or dextrose 5 % (D5W) in 3 types of infusion bags (Easyflex® and Viaflo® at 25 °C, Freeflex® between 2 and 8 °C, protected from light). Methods The chemical stability was analyzed after preparation and then after 14 and 28 days of storage by high performance liquid chromatography (HPLC), coupled to a diode array detector, at the analysis wavelength of 232 nm. The method has been validated according to ICH Q2 (R1) standards. For the study in infusion bags, three preparations were realised for each condition. At each time of analysis, for each bag, a sample was prepared and analyzed by HPLC. Two vials after “openings” were kept at 25 °C and three samples per vial were prepared and analyzed at the three analysis times (D0, D14 and D28). Physical stability was assessed by visual examination (change in colour, appearance of precipitate, gas formation). The pH of the solutions prepared in infusion bags was evaluated at each analysis time. Results Cabazitaxel solutions at 0.1 and 0.26 mg/mL diluted in 0.9 % NaCl or D5W in Easyflex® (polyolefin), Viaflo® (multilayer high density polyethylene, polyamide, polypropylene) bags retained more than 95 % of the concentration after 28 days at 25 °C. In the Freeflex® bag (polypropylene multilayers), cabazitaxel solutions at 0.1 and 0.26 mg/mL diluted in 0.9 % NaCl or D5W retained more than 95 % of the initial concentration between 2 and 8 °C for 28 days. In vials with a Spike, cabazitaxel solutions at 20 mg/mL retained more than 95 % of the initial concentration for 28 days at 25 °C. For all the conditions studied, no visual modification was observed. The pH of solutions in bags were constant during the stability study. Conclusions Cabazitaxel Zentiva® diluted at 0.1 and 0.26 mg/mL in 0.9 % NaCl or D5W was stable for 28 days at 25 °C and between 2 and 8 °C. These stability data allow preparations to be made in advance. The remainder of the cabazitaxel vial fitted with a Spike was stable for 28 days at 25 °C, allowing the remainder of the vial to be used over several days.

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology (medical),Pharmacology,Pharmacy

Reference16 articles.

1. Cabazitaxel Zentiva 20 mg/ml concentrate for solution for infusion. In: Summary of product characteristics Updated 29-Oct-2021: Zentiva. Available from: https://www.medicines.org.uk/emc/product/13007/smpc

2. Jevtana® 60 mg concentrate and solvent for solution for infusion. Summary of Product Characteristics Updated 21-June-2022. Available from: https://www.medicines.org.uk/emc/product/4541.

3. Cabazitaxel Tillomed 60 mg concentrate and solvent for solution for infusion. In: Summary of product characteristics. Updated 08-Feb-2022: Tillomed Laboratories Ltd.

4. Cabazitaxel EVER pharma 10 mg/ml concentrate for solution for infusion. Summary of Product Characteristics Updated 30-Jun-2021. EVER Valinject GmbH/Kent Pharma UK Ltd. Available from: https://www.medicines.org.uk/emc/product/12687/smpc.

5. Cabazitaxel accord healthcare limited 20 mg/ml concentrate for solution for infusion. Summary of Product Characteristics Updated 18-August-2022. Available from: https://www.medicines.org.uk/emc/product/12332/smpc.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3